Sun-Ho Lee

Assistant Professor, Clinician Scientist

Mount Sinai Hospital

Canada

Research Interests

Explore related searches

Professors in Canada Professors in Immunology Immunology professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Sun-Ho Lee is an Assistant Professor and Clinician Scientist at Mount Sinai Hospital in Canada. His research focuses on inflammatory bowel disease (IBD), with recent articles exploring molecular pathways linked to Crohn's Disease, the gut microbiome, and potential targets for precision prevention of IBD. He has investigated the impact of various factors on disease progression and treatment responses in patients with Crohn's Disease.

Articles (7)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2022

Year:

2021

Year:

2020

Collaborators (5)

Sung Wook Hwang

Professor

Asan Medical Center

SOUTH KOREA

View details

Andrew Paterson

Professor, Epidemiology and Biostatistics

University of Toronto

CANADA

View details

Dong-Hoon Yang

Professor

Asan Medical Center

SOUTH KOREA

View details

Hien Q. Huynh

CANADA

View details

Karen Madsen

Professor

University of Alberta

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sun-Ho Lee

Research Interests

Explore related searches

Contact this professor

About

Articles (7)

Metabolomics reveal distinct molecular pathways associated with future risk of Crohn’s Disease

Identifying Potential Targets for the Interception of Inflammatory Bowel Disease: Toward Precision Prevention

Isolated Anastomotic Ulcers Are Associated with a Higher Long-Term Risk for Postoperative Recurrence and a Differential Mucosa-Associated Microbiome Composition in Patients with Crohn’s Disease Following Ileocolic Resection

Inflammatory Bowel Disease Associated with Primary Sclerosing Cholangitis is Associated with an Altered Gut Microbiome and Bile Acid Profile

Fecal S100A12 is associated with future hospitalization and step-up of medical treatment in patients with Crohn’s disease in clinical remission: a pilot study

Anti-Microbial Antibody Response is Associated With Future Onset of Crohn's Disease Independent of Biomarkers of Altered Gut Barrier Function, Subclinical Inflammation, and Genetic Risk

Changes in prevalence and perception of complementary and alternative medicine use in Korean inflammatory bowel disease patients: results of an 8-year follow-up survey

Collaborators (5)

Sung Wook Hwang

Andrew Paterson

Dong-Hoon Yang

Hien Q. Huynh

Karen Madsen

Make your next move.